--- a
+++ b/clusters/9knumclustersv2/clust_1493.txt
@@ -0,0 +1,86 @@
+Have an expected survival of ? months.
+Expected survival >=  months after consenting
+Expected survival of ?  weeks, in the opinion of the investigator.
+Must have an expected survival of at least three months.
+Expected survival of ?  weeks.
+Expected survival of at least  months.
+Expected survival >  months from study enrollment
+Have expected survival of at least  months
+Expected survival of >  days
+Expected survival ?  months
+Another cancer with expected survival of <  years
+Expected survival must be greater than three months
+Expected survival >  months
+Have expected survival of at least  months
+Expected survival <  months
+Expected survival of at least  years
+Expected survival ?  months.
+Expected survival must be greater than  months
+Expected survival is greater than  days
+Expected survival of more than  weeks;
+Expected survival >  months
+Patients must have an expected survival of >  days and must be free of major infection
+Must have an expected survival status of at least  months
+Expected survival >  months
+Expected survival >  weeks
+Expected survival >  months
+Expected survival >  months
+Expected survival if untreated of >  days
+Non-hematopoietic malignancy where the expected survival is less than  years
+Expected survival ?  months.
+Expected survival >  months.
+Concurrent active malignancy with expected survival of less than  year. For example, candidates with treated skin cancers, prostate cancer, breast cancer, etc. without metastatic disease are candidates for therapy since their expected survival exceeds that of relapsed or refractory AML. All subjects with concurrent malignancies will be reviewed by the principal investigator (PI) prior to enrollment.
+Expected survival ?  months
+Expected survival ?  months in the view of the PI or investigators
+Expected survival of greater than  weeks.
+May not have prior malignancies unless the expected survival is at least  years
+Expected survival >=  months
+Expected survival > months
+Expected survival >  months
+Patients must have an expected survival of >  days and must be free of major infection
+Expected survival <  months
+Patients must have an expected survival of >  days and must be free of major infection
+Expected survival if untreated less than  days
+Patient must have expected survival of ? months
+Expected survival of at least  months
+Expected survival >  weeks at the time of screening
+Patients must have an expected survival of >  days and must be free of major infection
+Have an expected survival of >  days
+Expected survival duration of >  months
+Patients with expected survival <  weeks
+Expected survival >  months
+Subjects must have expected survival of ? months.
+Expected survival >  month
+Expected survival of at least  months
+Expected survival >  months
+Expected survival ?  months.
+Expected survival >  months
+Expected survival time of >=  months in the opinion of the investigator
+Expected survival ? months.
+Expected survival >  weeks
+Expected survival time of >=  months in the opinion of the investigator
+Expected survival time of at least  months in the opinion of the investigator
+Patients must have an expected survival of >  days and must be free of active infection
+Expected survival duration of >= six months
+Patients must have an expected survival of >  days and must be free of active infection
+Expected survival >=  months from study entry
+Expected survival ?  months.
+Expected survival >  months
+Expected survival of at least  months.
+Expected survival must be three months or greater
+Participants with a serious medical illness which may limit expected survival to less than  months
+Expected survival of at least  months.
+Expected survival longer than  months from enrollment in the study
+Have expected survival of ? months.
+Expected survival >  months
+Expected survival <  months
+Expected survival of at least  months
+Minimal expected survival time of one month
+Expected survival of at least  months
+Karnofsky performance status >= , with expected survival of >=  months
+Expected survival >  months
+Expected survival longer than  months from enrollment in the study.
+Expected survival of at least  months from the date of enrollment in the study.
+Expected survival is >  days
+Expected survival of more than  months.
+Expected survival of at least  weeks after dosing.